Table 4 Plasma levels of Hsp90α in patients with liver cancer with different clinicopathological characteristics

Sex

Male

87

207.79 ± 144.91

0.153

Female

31

180.35 ± 140.34

Age

< 60

66

221.23 ± 160.92

0.184

≥ 60

52

174.38 ± 114.34

History of hepatitis

Yes

59

245.14 ± 181.37

0.024

No

59

156.02 ± 68.42

History of cirrhosis

Yes

39

269.71 ± 206.83

0.040

No

79

166.45 ± 80.85

Active stage of liver disease

Yes^*

17

221.05 ± 148.62

0.040

No

17

134.07 ± 26.79

Child-Pugh

A/B

59

155.21 ± 100.03

0.025

C

59

255.26 ± 171.48

Morbidity

1st Occurrence

118

217.75 ± 104.27

0.042

Recurrence

33

136.12 ± 49.23

Source

Primary

91

190.38 ± 125.72

0.038

Secondary

27

249.78 ± 154.61

Primary organs of secondary liver cancer

Colorectal

10

221.90 ± 192.85

0.896

Stomach

3

133.89 ± 41.05

Pancreas

4

205.56 ± 137.48

Other

10

220.12 ± 186.96

Size of focal liver lesions

< 3 cm

10

123.31 ± 26.01

0.006

3 cm

22

177.71 ± 54.33

Extrahepatic metastasis

Yes

33

277.20 ± 183.01

< 0.001

No

22

115.11 ± 61.26

N/A

63

212.24 ± 133.91